Manufacturing channel feed – Endpoints News

The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Q&A: How Penn's CAR-T manufacturing discovery has drastically reduced timelines

4 years ago

Fujifilm completes acquisition of Atara's cell therapy manufacturing site near Los Angeles

4 years ago

Quality metrics for pharma manufacturing is back in a big way, with FDA pledging to 'objectively rate' firms

4 years ago

Catalent wins bidding war to take on UK's VMIC

4 years ago

Co-founder of Florida pharma indicted after multistate bacterial outbreak at children's hospitals

4 years ago

Novartis manufacturing facility in North Carolina gets FDA all-clear to produce, ship gene therapies

4 years ago

Boehringer Ingelheim boosts R&D commitment, promises up to 15 new product launches by 2025

4 years ago

Ontario antes up $580M for C&G therapy plant in Hamilton

4 years ago

Sanofi's plan to list its API spinout in France is a go

4 years ago

Q&A: Lonza's Christian Dowdeswell talks HPAPIs and the Oasmia deal

4 years ago

Bayer to dump $2.26B into manufacturing realignment as it says goodbye to some sites

4 years ago

AGC to use recently-expanded Germany site for peanut allergy drug trials

4 years ago

India offers incentives to domestic drugmakers for APIs; After PhIII trials, Taiho licenses Arokaris in Japan

4 years ago

A team at Penn says it has slashed CAR-T cell therapy manufacturing timeframe to just 24 hours

4 years ago

Peter Hotez and Maria Bottazzi's 'forgotten' vaccine approved in Botswana

4 years ago

Biden likely to sign a bill that would crack down on China's chokehold on the antibiotic supply

4 years ago

Belgian CDMO offers new LNP service as demand for RNA-delivery services heats up

4 years ago

Jazz plots massive growth for UK cannabinoid operations

4 years ago

In quick turn, ten23 already looking to expand Visp fill-finish site

4 years ago

Merck to stop making APIs at Pennsylvania site and cut 300 jobs by 2024

4 years ago

Q&A: In an often-overlooked part of the state, a small Massachusetts CMO has its first FDA approval

4 years ago

Sobi closes out 24-year partnership with Pfizer; Belgian Exothera site gets thumbs up from FDA

4 years ago

Takeda's rare disease drug's manufacturing and supply woes continue as FDA rejects supplement

4 years ago

Amid inspection and recall woes, Aurobindo to shut down NJ site in April

4 years ago

First page Previous page 54 55 565758 59 60 Next page Last page